Skip to main content
Indietro

Study Notes: Gram-Positive and Gram-Negative Cocci of Medical Importance (Staphylococcus & Streptococcus)

Guida di studio - Note intelligenti

Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.

Chapter 18: The Gram-Positive and Gram-Negative Cocci of Medical Importance

Staphylococci: General Characteristics

Staphylococci are a diverse group of Gram-positive cocci commonly found on the skin and mucous membranes. They are important in both normal flora and as opportunistic pathogens.

  • Habitat: Common inhabitant of skin and mucous membranes.

  • Cell Morphology: Spherical cells arranged in irregular clusters.

  • Gram Reaction: Gram-positive.

  • Spores/Flagella: Lack spores and flagella.

  • Capsules: May have capsules.

  • Diversity: More than 40 species identified.

Staphylococcus aureus: Characteristics and Growth

Staphylococcus aureus is the most clinically significant species, known for its robust growth and resistance to environmental stress.

  • Colony Morphology: Large, round, opaque colonies.

  • Optimal Temperature: 37°C.

  • Oxygen Requirement: Facultative anaerobe.

  • Environmental Resistance: Withstands high salt, extremes in pH, and high temperatures.

  • Virulence: Produces many virulence factors.

Virulence Factors of S. aureus

S. aureus possesses a wide array of enzymes and toxins that contribute to its pathogenicity.

Name

Enzyme/Toxin

Effect

Coagulase

Enzyme

Coagulates blood plasma

Hyaluronidase

Enzyme

Digests connective tissue of the host

Staphylokinase

Enzyme

Digests blood clots

Lipase

Enzyme

Digests oils, allowing bacteria to colonize skin

Penicillinase

Enzyme

Inactivates penicillin

Hemolysins (α, β, γ, δ)

Toxin

Lyse red blood cells

Leukocidin

Toxin

Lyse neutrophils and macrophages

Enterotoxins

Toxin

Induce nausea, vomiting, diarrhea

Exfoliative toxins (A, B)

Toxin

Cause desquamation of the skin

Toxic shock syndrome toxin

Toxin

Induces fever, vomiting, rash, organ damage

Epidemiology and Pathogenesis of S. aureus

S. aureus is widespread in human environments and can be carried asymptomatically.

  • Reservoir: Present in most environments frequented by humans.

  • Transmission: Readily isolated from fomites.

  • Carriage Rate: 20-60% of healthy adults, mainly in anterior nares, skin, nasopharynx, intestine.

  • Risk Factors: Poor hygiene, tissue injury, preexisting infection, diabetes, immunodeficiency.

  • Antibiotic Resistance: Increase in community-acquired methicillin resistance (MRSA).

Staphylococcal Disease: Clinical Manifestations

Diseases caused by S. aureus range from localized skin infections to severe systemic illnesses.

Localized Cutaneous Infections

  • Folliculitis and Hidradenitis: Superficial inflammation of hair follicles and glands; usually resolves but can progress.

  • Furuncle: Boil; inflammation of hair follicle or sebaceous gland, progresses into abscess or pustule.

  • Carbuncle: Larger, deeper lesion from aggregation of furuncles.

  • Impetigo: Bubble-like swellings that break and peel away; common in newborns.

Systemic Infections

  • Osteomyelitis: Infection in bone metaphysis; abscess formation.

  • Bacteremia: Bacteria from other infected sites or medical devices; risk of endocarditis.

Toxigenic Diseases

  • Food Intoxication: Ingestion of heat-stable enterotoxins; causes gastrointestinal distress.

  • Staphylococcal Scalded Skin Syndrome: Toxin induces red flush, blisters, desquamation of epidermis.

  • Toxic Shock Syndrome: Toxemia leading to shock and organ failure.

Other Important Staphylococci

Coagulase-negative staphylococci are significant in healthcare-associated and opportunistic infections, especially in immunocompromised patients.

  • S. epidermidis: Skin and mucous membranes; endocarditis, bacteremia, UTI.

  • S. hominis: Around apocrine sweat glands.

  • S. capitis: Scalp, face, external ear.

  • S. saprophyticus: Skin, intestine, vagina; UTI.

Identification of Staphylococcus

Laboratory identification is essential for diagnosis and treatment.

  • Sample Sources: Pus, tissue exudates, sputum, urine, blood.

  • Tests: Cultivation, catalase test, biochemical testing, coagulase test.

Key Laboratory Tests

  • Catalase Test: Differentiates staphylococci (catalase-positive) from streptococci (catalase-negative).

  • Coagulase Test: Differentiates S. aureus (coagulase-positive) from other staphylococci.

Identification Flowchart for Clinically Important Species of Staphylococcus

Characteristic

Species

Coagulase-positive

S. aureus

Coagulase-negative, anaerobic growth, ferments mannose

S. epidermidis

Coagulase-negative, anaerobic growth, does not ferment mannose

S. saprophyticus

Coagulase-negative, anaerobic growth, no urease production

S. capitis

Coagulase-negative, no anaerobic growth

S. hominis

Clinical Concerns in Staphylococcal Infections

  • Antibiotic Resistance: 95% produce penicillinase; resistant to penicillin and ampicillin.

  • MRSA: Methicillin-resistant S. aureus; multiple drug resistance, some strains only sensitive to vancomycin.

  • Treatment: Abscesses require surgical drainage; systemic infections need intensive therapy.

Treatment of Staphylococcal Infections

  • S. aureus: Cephalexin, sulfa drugs, tetracyclines, clindamycin for less resistant forms.

  • MRSA: Vancomycin, ceftaroline, linezolid, daptomycin; combination therapy to reduce resistance.

  • VISA/VRSA: Quinupristin/dalfopristin as last resort.

Prevention of Staphylococcal Infections

  • Universal Precautions: Healthcare providers must prevent nosocomial infections.

  • Carrier Management: Nasal carriers may be restricted from sensitive hospital areas; treated with antimicrobials.

  • Hygiene: Regular cleansing reduces risk.

  • Vaccines: Vaccine against S. aureus in clinical trials.

Concepts Check

  • Which test differentiates S. aureus from other Staphylococci species? Answer: D. Coagulase

General Characteristics of Streptococci and Related Genera

Streptococci are Gram-positive cocci, often found in chains or pairs, and are important pathogens in humans.

  • Cell Morphology: Spherical/ovoid cocci in chains or pairs.

  • Spores/Flagella: Non-spore-forming, nonmotile.

  • Capsules/Slime Layers: Can form capsules and slime layers.

  • Oxygen Requirement: Facultative anaerobes.

  • Catalase: Do not form catalase; have peroxidase system.

  • Colony Morphology: Small, nonpigmented colonies.

  • Sensitivity: Sensitive to drying, heat, disinfectants.

Separation of Streptococcal Subgroups

Streptococci are classified by Lancefield groups (cell wall carbohydrates) and hemolysis patterns.

  • Lancefield Groups: 20 groups (A, B, C, ...).

  • Hemolysis: β-hemolytic: Groups A, B, C, G, some D strains α-hemolytic: S. pneumoniae, viridans group

Species of Streptococcus and Related Genera

Species

Lancefield Group

Hemolysis Type

Habitat

Pathogenicity to Humans

S. pyogenes

A

Beta (β)

Human throat

Skin, throat infections, scarlet fever

S. agalactiae

B

β

Human vagina, cow udder

Neonatal, wound infections

Enterococcus faecalis

D

α, β, N

Human, animal intestine

Endocarditis, UTI

S. pneumoniae

---

α

Human respiratory tract

Bacterial pneumonia

Beta-Hemolytic Streptococci: Streptococcus pyogenes

S. pyogenes is the most serious streptococcal pathogen, strictly parasitic, inhabiting the throat, nasopharynx, and occasionally skin.

Virulence Factors of S. pyogenes

Name

Function

C-carbohydrate

Protects from lysozyme; basis for Lancefield groups

Fimbriae

Adherence to epithelial cells

M-protein

Resists phagocytosis; >80 subtypes

Capsule

Adhesion and immune evasion

C5a protease

Cleaves C5a protein, inhibits complement system

  • Streptolysins: Hemolysins (SLO, SLS) cause cell and tissue injury.

  • Erythrogenic toxin: Induces fever and red rash.

  • Superantigens: Stimulate monocytes/lymphocytes, release necrotic factor.

  • Streptokinase: Digests fibrin clots.

  • Hyaluronidase: Breaks down connective tissue.

  • DNase: Hydrolyzes DNA.

Epidemiology and Pathogenesis of S. pyogenes

  • Reservoir: Humans only.

  • Transmission: Contact, droplets, food, fomites.

  • Portal of Entry: Skin or pharynx.

  • Risk Group: Children are most affected.

  • Complications: Systemic infections and sequelae if untreated.

Scope of Clinical Disease: S. pyogenes

Skin Infections

  • Impetigo (pyoderma): Superficial, contagious crusted lesions; common in children.

  • Erysipelas: Spreads to dermis/subcutaneous tissue; can be systemic.

Necrotizing Fasciitis (Flesh-Eating Disease)

  • Rapid spread through subcutaneous tissue; severe disfigurement or death.

  • Enzymes digest tissue; toxins poison skin layers; some act as superantigens.

Concepts Check

  • Which of the following is NOT a possible complication of strep throat? Answer: D. Otitis media

Additional info:

  • Tables and flowcharts have been expanded for clarity and completeness.

  • Images referenced in the slides are described in text for study purposes.

Pearson Logo

Study Prep